Search results
Results from the WOW.Com Content Network
Cardiomegaly can be classified by the main enlarged location of the heart, and/or by the structure of the enlargement. Specific subtypes include athletic heart syndrome, which is a non-pathological condition commonly seen in sports medicine in which the heart is enlarged, and the resting heart rate is lower than normal.
It is also important to control heart disease risk factors including diabetes, high cholesterol, and high blood pressure. Exercise, pregnancy, and prior health conditions like ASD II can also promote cardiac remodeling, so routine primary care visits are important to distinguish between physiological and pathological atrial enlargement.
Athletic heart syndrome (AHS) is a non-pathological condition commonly seen in sports medicine in which the human heart is enlarged, and the resting heart rate is lower than normal. The athlete's heart is associated with physiological cardiac remodeling as a consequence of repetitive cardiac loading. [ 3 ]
Special report: As delays in NHS cardiology services soar, experts and doctors warn patients are dying and coming to harm as they’re left languishing waiting for specialist care, writes Rebecca ...
For premium support please call: 800-290-4726 more ways to reach us
Liverpool Heart and Chest Hospital NHS Foundation Trust is an NHS foundation trust located in the suburb of Broadgreen within the city of Liverpool, England.It manages the Liverpool Heart and Chest Hospital which serves the population of Merseyside, North West England, North Wales and the Isle of Man but also provides some specialist services for patients from all areas of the United Kingdom ...
Other considerations for causes of enlarged heart are athlete's heart and hypertension (high blood pressure). [10] Making the diagnosis of HCM often involves a family history or pedigree, an electrocardiogram, echocardiogram, and stress testing. [7] Genetic testing may also be done. [7]
The trust was under the leadership of chair Jacqui Smith and chief executive David Rosser, who succeeded Julie Moore on 1 September 2018. In September 2016 HEFT announced plans to merge with the University Hospitals Birmingham NHS Foundation Trust. [2] The merger took place on 1 April 2018.